A detailed history of Black Rock Inc. transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Black Rock Inc. holds 615,581 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
615,581
Previous 622,983 1.19%
Holding current value
$0
Previous $26 Million 0.13%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$40.97 - $43.33 $303,259 - $320,728
-7,402 Reduced 1.19%
615,581 $26.1 Million
Q4 2023

Feb 13, 2024

BUY
$32.77 - $42.31 $1.35 Million - $1.74 Million
41,093 Added 7.06%
622,983 $26 Million
Q3 2023

Nov 13, 2023

BUY
$35.46 - $40.13 $1,843 - $2,086
52 Added 0.01%
581,890 $21.9 Million
Q2 2023

Aug 11, 2023

BUY
$24.24 - $40.97 $10.2 Million - $17.3 Million
422,645 Added 265.49%
581,838 $22.1 Million
Q1 2023

May 12, 2023

SELL
$23.0 - $31.59 $314,364 - $431,772
-13,668 Reduced 7.91%
159,193 $3.87 Million
Q4 2022

Feb 13, 2023

SELL
$27.6 - $32.99 $252,871 - $302,254
-9,162 Reduced 5.03%
172,861 $5.02 Million
Q3 2022

Nov 14, 2022

BUY
$28.74 - $39.9 $409,372 - $568,335
14,244 Added 8.49%
182,023 $5.46 Million
Q2 2022

Aug 12, 2022

SELL
$35.0 - $43.59 $209,545 - $260,973
-5,987 Reduced 3.45%
167,779 $6.07 Million
Q1 2022

May 12, 2022

SELL
$43.12 - $50.3 $168,340 - $196,371
-3,904 Reduced 2.2%
173,766 $7.52 Million
Q4 2021

Feb 10, 2022

BUY
$47.6 - $65.0 $191,209 - $261,105
4,017 Added 2.31%
177,670 $8.9 Million
Q3 2021

Nov 09, 2021

BUY
$62.34 - $73.38 $331,835 - $390,601
5,323 Added 3.16%
173,653 $11 Million
Q2 2021

Aug 11, 2021

BUY
$70.26 - $76.64 $11.8 Million - $12.9 Million
168,330 New
168,330 $12.1 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.